Published in Ann Surg on August 01, 1989
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci (2007) 1.02
Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut (1999) 0.97
Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg (2010) 0.87
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci (1998) 0.86
Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Dig Dis Sci (2009) 0.84
Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol (2014) 0.78
Changes in splenic volume during liver regeneration. World J Surg (2004) 0.78
Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type. World J Gastroenterol (2008) 0.77
Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology. Springerplus (2013) 0.77
Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci (2000) 0.77
Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol (2006) 0.75
Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process. BMC Hematol (2016) 0.75
The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis. Gastroenterol Hepatol (N Y) (2017) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Hyperglobulinaemia in liver disease. Lancet (1973) 2.74
Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet (1973) 2.15
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg (1977) 1.22
The effect of the distal splenorenal shunt on hypersplenism. Ann Surg (1977) 1.12
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg (1982) 1.08
Correction of hypersplenism following distal splenorenal shunt. Surgery (1979) 1.02
The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet (1974) 0.98
The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med (1961) 0.95
Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis. Am Surg (1979) 0.88
[Exercise therapy for patients with acute myocardial infarct under strict and less-restricted confinement to bed]. Med Sestra (1972) 0.81
Evolution of liver transplantation. Hepatology (1982) 19.54
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med (1975) 5.53
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun (1987) 4.68
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Responsiveness to HY antigen Ir gene complementation and target cell specificity. Immunol Rev (1977) 3.03
Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science (2001) 3.02
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91
Liver transplantation in adults. Hepatology (1982) 2.89
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80
Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
Executive control of visual attention in dual-task situations. Psychol Rev (2001) 2.69
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66